Executive DirectorCSL Behring Innovation GmbHMarburg, Hessen, Germany
PB1030 - Hemostatic Evaluation of Synthetic Platelet Nanotechnology in Rabbit Models of Dilutional Coagulopathy and Trauma
Tuesday, June 27, 202318:30 – 19:30 ET
PB1090 - Modelling the effects of 4-factor prothrombin complex concentrate for the management of factor Xa inhibitor-associated bleeding
